|
Click here
to view this message in a web browser |
||
|
Hospital Price Transparency Implications: Fallout from the CMS Final Rule Effective in 2021 Thursday, February 6th, 2020 | 1:00PM - 1:45PM Eastern |
||
Faculty: Stephanie W. Kanwit, Of Counsel,
Epstein Becker Green |
||
 |
||
|
The Centers for Medicare & Medicaid Services
(“CMS”) recently issued a final rule requiring hospitals to publicly
disclose their rates, including negotiated rates with third-party payors
regardless of product line, by January 1, 2021. The Final Rule’s intent
is to increase price transparency so that health care consumers can
“shop” for health care services. The Final Rule does not exclude any
particular type of health plan, product, or line of business, except for
rates that are not negotiated (e.g., fee-for-service Medicare or
Medicaid). Hospitals that are deemed non-compliant are subject to fines
of up to $300 per day, up to a maximum of $109,500 per year. In addition to covering the provisions and scope of the Final Rule, and how the Final Rule would impact both hospitals and consumers when making health care decisions, this session will demonstrate by means of illustrative example how a potential patient could make use of the data required by the Final Rule and the limitations hospitals will have in providing reliable information. |
||
 |
||
Please join us on Thursday, February 6, 2020, at 1 PM Eastern as Epstein Becker Green's Stephanie W. Kanwit examines the provisions, complexities, challenges, implications and outcomes of the CMS Hospital Price Transparency Final Rule. Click here for detailed information or to register or call 209.577.4888. |
|
healthexecwire |